|
|
|
| home > epc > winter 2003 > automation in a validated environment fuels big business rewards |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
Integrated building management solutions incorporating comprehensive electronic record keeping and signature capabilities can go a long way to fulfilling the pharmaceutical industry's threefold mantra of regulatory compliance, productivity gain and faster time-to-market. Never before has there been so much emphasis on the environment within which critical-to-quality processes for pharmaceuticals, biotechnology products and medical devices take place. In research labs, manufacturing areas and warehouses, conditions such as temperature, humidity, pressure, air particulate levels and access must be monitored, safely archived and easily retrieved for reporting purposes and audit - local, European and US Food & Drug Administration (FDA) audit alike.
But how is it best to implement compliant environmental control in a complex and mission-critical framework? Pharmaceutical manufacturers across Europe are always hungry for new, smarter ways of working. I am asked the same questions wherever I go:
How can we use raw data feeds to eliminate internal bottlenecks?
How can we make the shift from paper-based to automated, electronic records and signature?
How can we use building automation technology to refine processes, reduce costs and speed time-to-market?
How can we integrate FDA-compliant environmental control solutions into an enterprise-wide pharmaceutical operation?
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Exploratory Clinical Development World Europe 2012
23-24 May 2012, The Business Design Centre, London, UK
Now in its 6th year, Exploratory Clinical Development World Europe has established itself as the largest & most influential European event for top pharma & biotech representatives working within exploratory development & early phase clinical trials.
More info >> |
|
 |
News and Press Releases |
 |
APTAR PHARMA CELEBRATES ASTHMA DAY WITH A TWISTER™ OF INNOVATION
World leader in the development and manufacturing of nasal and pulmonary drug delivery devices including inhalers for asthma, Aptar Pharma launches Twister™, a new versatile affordable capsule-based Dry Powder Inhaler (DPI) specifically targeting fast growing markets.
More info >> |
|
|
